SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-002306
Filing Date
2024-03-04
Accepted
2024-03-04 06:22:53
Documents
18
Period of Report
2024-03-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240301x8k.htm   iXBRL 8-K 51158
2 EX-99.1 chrs-20240301xex99d1.htm EX-99.1 17144
3 EX-99.2 chrs-20240301xex99d2.htm EX-99.2 583219
4 GRAPHIC chrs-20240301xex99d1001.jpg GRAPHIC 9946
  Complete submission text file 0001558370-24-002306.txt   834362

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20240301.xsd EX-101.SCH 4155
6 EX-101.DEF chrs-20240301_def.xml EX-101.DEF 3156
7 EX-101.LAB chrs-20240301_lab.xml EX-101.LAB 15905
8 EX-101.PRE chrs-20240301_pre.xml EX-101.PRE 10733
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240301x8k_htm.xml XML 4855
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 24712779
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)